Tag: John S Barbieri MD

All

Dermatologists and patients with psoriatic disease approve of a specialist-led model of care, HealthDay reports.

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.